Testing effectiveness (Phase 2)Study completedNCT01072695
What this trial is testing
Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection
Who this might be right for
HCV Infection
Gilead Sciences 46